BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6532807)

  • 1. The pharmacokinetics and biotransformation of 14C-lisuride hydrogen maleate in rhesus monkey and in man.
    Hümpel M; Krause W; Hoyer GA; Wendt H; Pommerenke G
    Eur J Drug Metab Pharmacokinet; 1984; 9(4):347-57. PubMed ID: 6532807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of lisuride hydrogen maleate in rat, rabbit and rhesus monkey.
    Humpel M; Toda T; Oshino N; Pommerenke G
    Eur J Drug Metab Pharmacokinet; 1981; 6(3):207-19. PubMed ID: 7308240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of lisuride in the hemoglobin-free perfused rat liver and in the whole animal.
    Toda T; Oshino N
    Drug Metab Dispos; 1981; 9(2):108-13. PubMed ID: 6113107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of bromerguride, a new dopamine-antagonistic ergot derivative in rat and dog.
    Hilderbrand M; Hümpel M; Krause W; Täuber U
    Eur J Drug Metab Pharmacokinet; 1987; 12(1):31-40. PubMed ID: 3609071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of the ergot derivative, transdihydrolisuride, in man.
    Krause W; Dorow R; Nieuweboer B; Hasan SH
    Eur J Clin Pharmacol; 1984; 27(3):335-9. PubMed ID: 6510462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoassay of plasma lisuride in man following intravenous and oral administration of lisuride hydrogen maleate: effect on plasma prolactin level.
    Hümpel M; Nieuweboer B; Hasan SH; Wendt H
    Eur J Clin Pharmacol; 1981; 20(1):47-51. PubMed ID: 7308272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
    Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E
    Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of 3H-terguride in elderly volunteers.
    Krause W; Kühne G; Seifert W
    Arzneimittelforschung; 1991 Apr; 41(4):373-7. PubMed ID: 1859510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of intravenous and oral 1,2-O-isopropylidene-3-O-3'-(N',N'-dimethylamino-n-propyl)-D-glucofuranose hydrochloride in the dog as a function of dose and characterization of metabolites.
    Garrett ER; Van Peer A
    J Pharm Sci; 1983 Sep; 72(9):1045-57. PubMed ID: 6631692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of oral lisuride in Parkinson's disease.
    Burns RS; Gopinathan G; Hümpel M; Dorow R; Calne DB
    Clin Pharmacol Ther; 1984 Apr; 35(4):548-56. PubMed ID: 6705456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, metabolism, excretion and plasma protein binding of 14C-levofloxacin after a single oral administration in the Rhesus monkey.
    Hemeryck A; Mamidi RN; Bottacini M; Macpherson D; Kao M; Kelley MF
    Xenobiotica; 2006 Jul; 36(7):597-613. PubMed ID: 16864506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys.
    Mattiuz E; Franklin R; Gillespie T; Murphy A; Bernstein J; Chiu A; Hotten T; Kassahun K
    Drug Metab Dispos; 1997 May; 25(5):573-83. PubMed ID: 9152596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the dopamine partial agonist, terguride, in the rat and rhesus monkey.
    Krause W; Hümpel M
    Eur J Drug Metab Pharmacokinet; 1988; 13(3):185-94. PubMed ID: 3240764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics and biotransformation of N-propylajmaline hydrogen tartrate in man].
    Hausleiter HJ; Achtert G; Khan MA; Kukovetz WR; Beubler E
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):329-39. PubMed ID: 7166185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics and biotransformation of the analgesic flupirtine in the rat and dog].
    Obermeier K; Niebch G; Thiemer K
    Arzneimittelforschung; 1985; 35(1):60-7. PubMed ID: 4039153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood level, distribution, excretion, and metabolite pattern of [14C]-brotizolam in the rat, dog, and rhesus monkey.
    Bechtel WD; Mierau J; Richter I; Stiasni M
    Arzneimittelforschung; 1986 Mar; 36(3A):568-74. PubMed ID: 3718579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics in man of the dopamine antagonist ergot derivative, bromerguride.
    Krause W; Sauerbrey N; Gräf KJ
    Eur J Clin Pharmacol; 1986; 31(2):165-8. PubMed ID: 3803415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition and metabolism of a new steroidal anti-inflammatory agent, deflazacort, in cynomolgus monkeys.
    Assandri A; Ferrari P; Perazzi A; Ripamonti A; Tuan G; Zerilli L
    Xenobiotica; 1983 Mar; 13(3):185-96. PubMed ID: 6613164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics and biotransformation of the new benzodiazepine lormetazepam in humans. I. Absorption, distribution, elimination and metabolism of lormetazepam-5-14C.
    Hümpel M; Illi V; Milius W; Wendt H; Kurowski M
    Eur J Drug Metab Pharmacokinet; 1979; 4(4):237-43. PubMed ID: 43806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and disposition of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent, in rat and monkey.
    DeLong AF; Martin GP; Polk A; Carter V; Herczeg T
    Arzneimittelforschung; 1978; 28(8a):1477-80. PubMed ID: 113016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.